Search results
Dr. Adam L. Green is a Pediatric Hematologist-Oncologist in Aurora, CO. Find Dr. Green's phone number, address, insurance information, hospital affiliations and more.
- Aurora, CO
- (720) 777-1234
Dec 1, 2021 · Introduction: Selinexor is a first-in-class, central nervous system (CNS) penetrant, oral inhibitor of exportin 1 (XPO1), the sole nuclear exporter of many key tumor suppressors. Selinexor is FDA-approved for refractory multiple myeloma and DLBCL and has been evaluated in a phase 1 trial in children with leukemia.
Dec 20, 2021 · Selinexor is an oral, first-in-class inhibitor of nuclear export, according to study author Adam L. Green, MD, a pediatric oncologist at the University of Colorado School of Medicine, Aurora, who explained that it functions by “binding to the nuclear export protein XPO1, and thus preventing export from the nucleus of key tumor ...
Results. For Cohort 1, 0.77% of patients receiving cranial RT developed RIG. 3.39% of patients receiving cranial RT for primary CNS tumors fell in cohort 2. Median latency to RIG diagnosis was 11.1 years and was significantly shorter for cohort 1b than 1a. Median OS for cohort 1 was 9.0 months.
Feb 24, 2020 · Abstract. Background: Hundreds of systemic chemotherapy trials in diffuse intrinsic pontine glioma (DIPG) have not improved survival, potentially due to lack of intratumoral penetration, which has not previously been assessed in humans.
Adam Green is a Pediatric Hematologist Oncology specialist and a Hematologist in Aurora, Colorado...
I help lead national clinical trials and give second opinions for other institutions for pediatric high-grade glioma, diffuse intrinsic pontine glioma (DIPG), and diffuse midline glioma. I also specialize in the diagnosis and management of other childhood tumors of the brain and spinal cord.
